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Abstract 
The synthesis, characterization and catalytic activity of new ruthenium complexes of 
the tris-N-pyrrolyl phosphine ligand P(pyr)3 is described. The new ruthenium complexes 
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[RuCl(ind)(PPh3){P(pyr)3}] and [RuCl(ind){P(pyr)3}2] (ind = indenyl ligand η5-C9H7−) 
were synthesized in 73% and 63% isolated yield, respectively, by thermal ligand exchange of 
[RuCl(ind)(PPh3)2] with P(pyr)3. The electronic and steric properties of the new complexes 
were studied through analysis of the X-Ray structures and through cyclic voltammetry. The 
new complexes [RuCl(ind)(PPh3){P(pyr)3}] and [RuCl(ind){P(pyr)3}2] and the known 
complex [RuCl(ind)(PPh3)2}] differed only slightly in their steric properties, as seen from the 
comparable bond lengths and angles around the ruthenium center. The oxidation potentials of 
[RuCl(ind)(PPh3){P(pyr)3}] and [RuCl(ind){P(pyr)3}2] are +0.34 and +0.71 Volt vs. 
Cp2Fe0/+, which are substantially higher than that of [RuCl(ind)(PPh3)2] (−0.023 V), which 
is in accordance with the enhanced π-acidity of the P(pyr)3 ligand. The new complexes are 
catalytically active in the etherification of propargylic alcohols and in the first ruthenium-
catalyzed formation of known and new xanthenones from propargylic alcohols and diketones 
(18 to 72 h at 90 °C in ClCH2CH2Cl or toluene, 1-2 mol-% catalyst, 69-22 % isolated yields).  
 
Introduction 
Transition metal complexes of ruthenium are utilized in applications for broad fields 
such as in catalysis[1] or for optical devices.[2] In medicinal organometallic chemistry 
ruthenium complexes are increasingly investigated as alternative to platinum-based anti-
cancer drugs (which are limited by side-effects).[1a,3,4] A plethora of ruthenium complexes is 
known, as are attempts to modify them in order to improve performance for their respective 
applications. Tuning of the electronic properties of ruthenium complexes is most commonly 
achieved through their ancillary ligands.[1c,4] Knowledge of the effect of ligands on 
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electronic (and steric) properties allows for the tailored synthesis of ruthenium complexes 
with unique properties for specialized applications.  
Phosphines are probably still the most widely utilized ligand class in the synthesis and 
application of ruthenium complexes,[5] albeit other ligands such as carbenes [6] or imines [7] 
are increasingly utilized. Phosphine ligands bearing aryl and alkyl groups are the most 
common ones used in metal complex syntheses, and their electronic modification is achieved 
through aryl substituents or through the nature of the alkyl groups.[8] While powerful, tuning 
options are somewhat limited at times, as in some cases they might require lengthy syntheses, 
hampering practical applications. The search for readily available phosphine ligands with 
unique electronic properties is, thus, ongoing.  
tris-N-Pyrrolyl phosphine is a readily accessible ligand with electronic properties 
different from the PPh3 ligand.[9] Research in the past decade has shown that tris-N-pyrrolyl 
phosphine (herein abbreviated P(pyr)3, pyr = N-pyrrolyl) exhibits increased π-acidity [10] 
with electronic properties similar to CO.[9] The electron-withdrawing properties of the ligand 
were demonstrated through the IR νCO stretching frequencies of its rhodium chloro carbonyl 
complex, which are frequently utilized to assess the electronic properties of a ligand.[9] Also, 
the oxidation potential, as determined by cyclic voltammetry, indicates the π-acidity of tris-N-
pyrrolyl phosphine.[11] Further electronic tuning is possible by placing electron-withdrawing 
substituents on the pyrrolyl ring.[12] A few ruthenium complexes of tris-N-pyrrolyl phosphine 
[13]
 and their catalytic applications are known (Figure 1).[11] Nevertheless, the chemistry of 
tris-N-pyrrolyl phosphine complexes of ruthenium is by far less explored than that of PPh3 
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and its analogs. We think that improved knowledge in the coordination chemistry of that 
ligand will open the pathway for its use in the synthesis of tailored ruthenium complexes.  
 
Figure 1. Representative tris-N-pyrrolyl phosphine complexes of ruthenium. 
 
As part of our long-standing research program directed towards the catalytic 
activation of propargylic alcohols,[14,15] we were interested in investigating electron-poor 
ruthenium complexes. Propargylic alcohols can be catalytically activated by ruthenium 
complexes,[16] for example through the formation of ruthenium allenylidene complexes 
[Ru=C=C=CR2]2+ [14,17] and we speculated that the reactivity of potential allenylidene 
intermediates with nucleophiles will increase with decreased electron-density at the metal. 
The known [18] ruthenium indenyl complex [RuCl(ind)(PPh3)2] (ind = η5-C9H7−) has 
previously been utilized as a starting material for organometallic syntheses [19] and ruthenium 
indenyl complexes are frequently applied in catalysis.[20] The increased reactivity of indenyl 
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complexes has been ascribed to the so called “indenyl effect”.[21] The formation of open 
coordination sites of the corresponding complexes is facilitated through an η5- η3 ring slip 
compared to the analogous cyclopentadienyl complexes. The effect has been ascribed through 
gain of aromaticity of the benzo portion of the ligand through a ring slip [21e] or related to the 
lower M-C bond energies of η5-indenyl complexes compared to η5-cyclopentadienyl.[21b] 
We were interested in synthesizing tris-N-pyrrolyl phosphine analogues of 
[RuCl(ind)(PPh3)2] in anticipation of accessing ruthenium complexes of increased Lewis 
acidity that will improve catalytic activity for the transformation of propargylic alcohols.  
Herein, we describe the synthesis and characterization of the ruthenium complexes 
[RuCl(ind)(PPh3){P(pyr)3}] and [RuCl(ind){P(pyr)3}2]. We assess the electronic properties 
of the new complexes through analysis of the X-Ray structures and through cyclic 
voltammetry. Finally, we demonstrate that the new complexes are catalytically active in the 
etherification of propargylic alcohols and in the first ruthenium catalyzed formation of 
xanthenones from propargylic alcohols and diketones.  
Results and Discussion 
Ligand and ruthenium complex syntheses.  
Several syntheses for the tris-N-pyrrolyl phosphine ligand P(pyr)3 have been 
described in the literature.[9, 10f] We prepared the ligand through a slightly modified literature 
procedure,[9] which is given in the Supporting Information. In general, it is important to work 
under moisture-free conditions and distill all starting materials immediately prior to use.  
The precursor complex [RuCl(ind)(PPh3)2] has been used as starting material for 
ruthenium complex syntheses through ligand substitution reactions by us [13, 14e,f] and 
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others.[22] Accordingly, when [RuCl(ind)(PPh3)2] was refluxed with 1.1 equivalents of 
P(pyr)3 in THF for 4 hours, the mono-pyrrolyl phosphine complex 
[RuCl(ind)(PPh3){P(pyr)3}] was isolated in 73% yield as a red solid after chromatographic 
workup (Scheme 1). In a second ligand exchange reaction, [RuCl(ind)(PPh3){P(pyr)3}] was 
refluxed with another equivalent of P(pyr)3 in THF for 5 hours. The bis pyrrolyl phosphine 
complex [RuCl(ind){P(pyr)3}2] was obtained in 63% yield as an orange yellow solid after 
column chromatography. Attempts to access [RuCl(ind){P(pyr)3}2] directly from 
[RuCl(ind)(PPh3)2] in a double ligand exchange reaction failed, as a mixtures of the mono- 
and disubstituted complexes resulted, which made workup difficult and lowered the yield.  
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Scheme 1. Synthesis of tris-N-pyrrolyl phosphine complexes of ruthenium. 
 
The new complexes were characterized by multinuclear NMR, MS, IR, elemental 
analysis and X-Ray diffraction. In the complex [RuCl(ind)(PPh3){P(pyr)3}], the coordination 
of one P(pyr)3 and one PPh3 ligand is readily indicated by two distinct 31P{1H} NMR signals 
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at 122.8 and 40.4 ppm, which exhibited a coupling constant 2JPP of 144 Hz, as expected for 
complexes with two magnetically different phosphorus atoms in the metal coordination 
sphere. Free P(pyr)3 resonates at 78.8 ppm in the 31P{1H} NMR spectrum, and the chemical 
shifts for the complex indicate coordination of the ligand. The complex 
[RuCl(ind){P(pyr)3}2] exhibited only one signal in the 31P{1H} NMR spectrum at 122.2 
ppm, as expected for two identical phosphorus atoms coordinated to the ruthenium center.  
The indenyl ligand gives very distinct 1H and 13C{1H} NMR signals for the three 
protons and the five carbon atoms of its coordinated five-membered ring.[23] Due to the 
unsymmetrical substitution pattern with four different ligands in [RuCl(ind)(PPh3){P(pyr)3}], 
all these carbons and protons are diastereotopic and give individual signals in the 
corresponding NMR spectra. In [RuCl(ind){P(pyr)3}2], the complex is symmetric, due to the 
two P(pyr)3 ligands, and chemically equivalent protons and carbon atoms give only one set of 
signals for the cyclopentadienyl portion of the complex, simplifying the 1H and 13C{1H} 
NMR spectrum.  
 
X-Ray structures  
In order to unequivocally establish the structure of the new ruthenium complexes, the 
X-ray structure of the complexes [RuCl(ind)(PPh3){P(pyr)3}] and [RuCl(ind){P(pyr)3}2] 
were determined (Tables 1 and Figure 2). Selected bond lengths and angles are listed in Table 
2, and for comparison purposes, the X-Ray data for [RuCl(ind)(PPh3)2] taken from the 
literature are also included.[24]  
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The bond angles for the monodentate ligands about the ruthenium center range from 
89.510(13)° to 99.008(14)°. The structures are, thus, best described as a slightly distorted 
octahedral. The greatest deviation from this ideal 90° angle are for both complexes the P(1)-
Ru-P(2) angles [97.89(5)° and 99.008(14)°], suggesting some steric repulsion between PPh3 
and P(pyr)3 and between the two P(pyr)3 ligands, respectively. Interestingly, the P(1)-Ru-
P(2) angles for both complexes are comparable, which demonstrates that the P(pyr)3 and the 
PPh3 ligands have similar steric demand.  
 
 
 
 
Figure 2. The molecular structures of [RuCl(ind)(PPh3){P(pyr)3}] (left) and 
[RuCl(ind){P(pyr)3}2]. Hydrogen atoms are omitted for clarity. Crystallographic parameters 
are compiled in Table 1, and key bond lengths and angles are listed in Table 2. 
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Table 1. Crystallographic Parameters 
 [RuCl(ind)(PPh3){P(pyr)3}] [RuCl(ind){P(pyr)3}2] Xanthenone 7b 
Empirical 
formula  
C39H34ClN3P2Ru C33H31ClN6P2Ru C27H24O3 
Formula weight  743.15 710.10 396.46 
Temperature K / 
Wavelength Å 
100(2) / 0.71073  100(2) / 0.71073 100(2) K / 0.71073Å 
Crystal system  Orthorhombic Monoclinic  Triclinic 
Space group  Pbca P21/c P1 
Unit cell 
dimensions 
a = 17.9518(15) Å 
b = 15.6316(12) Å 
c = 24.057(2) Å 
α= 90° 
β= 90° 
γ = 90° 
a = 13.2598(6) Å 
b = 9.5844(4) Å 
c = 24.8271(11) Å 
α= 90° 
β= 99.205(2)° 
γ = 90° 
a = 10.1854(6) Å  
b = 12.5276(7) Å 
c = 17.3162(9) Å  
α= 105.980(3)° 
β= 92.278(3)° 
γ = 107.377(3)° 
Volume / Z 6750.8(9) Å3 / 8 3114.6(2) Å3/ 4 2009.2(2) Å3/ 4 
Density 
(calculated) 1.462 Mg/m3 1.514 Mg/m3 1.311 Mg/m3 
Absorption 
coefficient 0.672 mm
-1
 0.726 mm-1 0.084 mm-1 
F(000) 3040 1448 840 
Crystal size / 
mm3 0.346 x 0.235 x 0.076 0.256 x 0.151 x 0.135  
0.298 x 0.275 x 
0.243 
Theta range for 
data collection 1.924 to 27.161° 1.556 to 36.325° 1.234 to 30.571° 
Index ranges -21≤h≤23,  
-20≤k≤15,  
-30≤l≤27 
-22≤h≤22,  
-15≤k≤14,  
-41≤l≤41 
-12≤h≤14,  
-17≤k≤17,  
-24≤l≤24 
Reflections 
collected 
78357 69845 48129 
Independent 
reflections 
7471 [R(int) = 0.0733] 15058 [R(int) = 0.0603] 12106 [R(int) = 
0.0413] 
Absorption 
correction 
Semi-empirical from 
equivalents 
Semi-empirical from 
equivalents 
Semi-empirical from 
equivalents  
Max. and min. 
transmission 
0.7989 and 0.7989 0.8625 and 0.7561 0.8879 and 0.8189 
Data / restraints / 
parameters 
7471 / 1 / 415 15058 / 0 / 388 12106 / 1 / 541 
Goodness-of-fit 
on F2 
1.003 1.019 
 
1.028 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0319,  
wR2 = 0.0.0604 
R1 = 0.0361,  
wR2 = 0.0745 
R1 = 0.0525,  
wR2 = 0.1314 
R indices (all 
data) 
R1 = 0.0596,  
wR2 = 0.0706 
R1 = 0.0559,  
wR2 = 0.0831 
R1 = 0.0892,  
wR2 = 0.1546 
Largest diff. peak 
and hole / e.Å-3 0.479 and -0.511  0.759 and -0.683  0.365 and -0.324 
 
  
10 
 
Table 2. Selected bond lengths and angles 
 
[RuCl(Ind)(PPh3){P(pyr)3}] [RuCl(Ind){P(pyr)3}2] [RuCl(Ind)(PPh3)2] 
Bond 
lengths (Å)  
   
Ru-P(1)  2.2323(15) (P(Pyr)3) 2.2042(4) 2.331 
Ru-P(2) 2.2760(14) (PPh3) 2.2716(4) 2.268 
Ru-Cl 2.4362(15) 2.4251(4) 2.437 
P(1)-N(X) a 
average
 
1.712 1.716 - 
P(1)-C(X) a 
average
 
1.831 - - 
Bond Angles 
(°) 
   
P(1)-Ru-
P(2) 
97.89(5) 99.008(14) 99.21 
Cl-Ru-P(1) 93.51(5) 90.684(14) 92.42 
Cl-Ru-P(2) 91.79(5) 89.510(13) 92.19 
Other 
geometrical 
parameters 
   
Ru-Cp (Å) b 1.902 1.928 1.918 
∆ Ru-C c 0.161 0.155 0.221 
Fold angle d  7.06° 7.33 7.07 
a
 P(1)-N(X) corresponds to the P-N bonds of P(pyr)3. P(1)-C(X) corresponds to the P-C 
bonds of PPh3 
b
 Distance between the Cp-centroid of the indenyl ligand and the ruthenium center. 
c
 Average difference between the Ru-C1, Ru-C2 and Ru-C9 bond lengths and the Ru-C3 and 
Ru-C8 bond lengths, see Figure 3. 
d
 Angle between the plane formed by C1-C2-C9 and by C2-C3-C8-C9, see Figure 3.  
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The Ru–P bond length for the P(pyr)3 ligand in [RuCl(ind)(PPh3){P(pyr)3}] 
[2.2323(15) Å] is only slightly shorter than that found for the PPh3 ligand [2.2760(14) Å], 
which might be due to increased backbonding from the ruthenium to the P(pyr)3 
ligand.[11,13a] Furthermore, in [RuCl(ind){P(pyr)3}2], the Ru–P bond length for both P(pyr)3 
ligands are also slightly different [2.2042(4) and 2.2716(4) Å, respectively], but fall in the 
range of other ruthenium P(pyr)3 complexes.[11,14e] Also, the distance between the Cp-
centroid of the indenyl ligand and the ruthenium center for both complexes are similar to 
each other (1.902 and 1.928 Å) and comparable to that found for [RuCl(ind)(PPh3)2] (1.918 
Å). Thus, the angles and the bond lengths for the P(pyr)3 ligand are comparable to the PPh3 
ligand and overall, the geometric parameters for the two P(pyr)3 complexes and 
[RuCl(ind)(PPh3)2] are similar, and the Ru-P(pyr)3 bond lengths are at best slightly shorter 
than the Ru-P(pyr)3 bond lengths.  
The P-N bond lengths of the P(pyr)3 ligand (1.712 and 1.716 Å) are slightly longer 
than the typical P-N bond lengths of phosphoramidite ligands R2NP(OR)2 (around 1.66 Å), 
suggesting a substantial P=N double bond character in the phosphoramidite ligand.[13a,14a] 
The elongated P-N bond lengths in the P(pyr)3 ligand are in accordance with aromatic 
delocalization of the nitrogen lone pair into the five-membered pyrrolyl ring as previously 
described,[9] preventing formation of a double bond with the phosphorus. 
As can be seen from the X-Ray structures, the indenyl ligands for both complexes are 
η5-coordinated, i.e. all five carbon atoms of the cyclopentadienyl unit form bonds to the 
ruthenium center. However, it has been described previously that the Ru-C bond lengths for 
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the coordinated cyclopentadienyl unit are not all of the same lengths as is the case for the two 
complexes described herein. As, with some exaggeration, illustrated in Figure 3 (top left), the 
cyclopentadienyl unit in indenyl complexes is typically slipped in a way that the bond lengths 
of the two benzenoid carbons are longer than the bond lengths to the other three carbon 
atoms. This has been ascribed to a gain in resonance energy for the aryl ring of the 
ligand.[21e] In an extreme case, only three of the five carbons would bond to the ruthenium 
center in an η3-fashion (Figure 3, top right).[21e] The degree of the slippage has previously 
been quantified by two parameters taken from X-Ray data, the ∆M-C value and the fold 
angle.[21e,25] The ∆M-C value is the average difference between the Ru-C1, Ru-C2 and Ru-
C9 bond lengths and the Ru-C3 and Ru-C8 bond lengths in the structures in Figure 2. Ideally, 
it is 0 and values around 0.2 Å are typical for indenyl ligands, indicating η5-coordination. The 
values for [RuCl(ind)(PPh3){P(pyr)3}] and [RuCl(ind){P(pyr)3}2] fall in this range. The fold 
angle is the angle between the plane formed by C1-C2-C8 and by C2-C3-C8-C9 (Figure 3, 
top right); it takes the value 0 in an ideal η5-coordination, and for indenyl complexes, the 
values typically range below 10°; again, [RuCl(ind)(PPh3){P(pyr)3}] and 
[RuCl(ind){P(pyr)3}2] fall in this range. An η3-coordination would be indicated by a fold 
angle around 60°.[21e]  
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Figure 3. Geometric parameters for indenyl complexes. 
 
However, what is interesting for the two complexes is which ligand takes the position 
trans to the C3 and C8 benzo-carbons of the cyclopentadienyl unit. It has been demonstrated 
before that the ligand with the strongest trans influence will take the positon trans to the 
benzo unit, weakening the bond strength (and enlarging the bond length) of the two Ru-C 
bonds of the benzo unit.[21e] In [RuCl(ind){P(pyr)3}2], one of the two P(pyr)3 ligands is 
located trans to the benzo-ring, indicating that P(pyr)3 has a stronger trans influence than 
chloride (B in Figure 3, bottom). However, in [RuCl(ind)(PPh3){P(pyr)3}], the PPh3 ring is 
located in the trans position (A in Figure 3, bottom), indicating that PPh3 has a stronger trans 
influence than P(pyr)3. This observation might be ascribed to the higher σ-basicity of PPh3 
compared to P(pyr)3, which leads to a stronger trans-influence.  
14 
 
The basicity of ligands has in the past been assessed through the vCO stretching 
frequencies of carbonyl complexes, and indeed, the value for P(pyr)3 is higher (2024 cm−1) 
than for PPh3 (1980 cm−1) in trans-[RhCl(CO)L2] (L = P(pyr)3, PPh3) indicating higher 
basicity of the latter.[9] Further evidence for the higher basicity of PPh3 compared to P(pyr)3 
are 31P-77Se coupling constants, which increase with decreasing basicity of the phosphorus 
compound.[26] In accordance with the higher basicity of PPh3, Se= P(pyr)3 exihibits a JP-Se 
value around 970 Hz, which is significantly higher than the corresponding value for Se=PPh3 
(735 Hz).[27] 
 
Cyclic Voltammetry 
Overall, the solid state structures of [RuCl(ind)(PPh3){P(pyr)3}] and 
[RuCl(ind){P(pyr)3}2] revealed some similarities between these two complexes and 
[RuCl(ind)(PPh3)2]. The structural parameters around the ruthenium center are comparable, 
corroborating earlier statements that the PPh3 and P(pyr)3 ligands are sterically similar. 
Electronic differences could be observed through the stronger trans influence of PPh3 
compared to P(pyr)3 and through the higher JP-Se coupling constants in Se= P(pyr)3. Cyclic 
voltammetry has been used before to characterize the electronic properties of ruthenium 
phosphine complexes.[28] To obtain further insight into the electronic properties of the new 
complexes, cyclic voltammograms were recorded of [RuCl(ind)(PPh3){P(pyr)3}] and 
[RuCl(ind){P(pyr)3}2], and also, for comparison, of [RuCl(ind)(PPh3)2]. The traces for a 
scan rate of 0.8 V/s are compiled in Figure 4.  
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Figure 4. Cyclic voltammetry of ruthenium indenyl complexes in 0.1M Bu4PF6 / 
CH2Cl2, 298K, recorded at a scan rate of 0.8 V/s. [RuCl(ind)(PPh3)2] (solid line), 
[RuCl(ind)(PPh3){P(pyr)3}] (dotted line ···), [RuCl(ind){P(pyr)3}2] (dashed line ---).  
 
The cyclic voltammogram of [RuCl(ind)(PPh3)2] shows a high degree of reversibility 
at different scan rates in that its ipc/ipa values are close to a value of 1 at all scan rates. The 
E°’ value for the oxidation is −0.023 V (vs. Cp2Fe0/+, Cp = cyclopentadienyl) and the peak 
current ratio ipc/ipa is 1.0 at a scan rate of 0.8 V/s. For the complexes 
[RuCl(ind)(PPh3){P(pyr)3}] and [RuCl(ind){P(pyr)3}2], the E°’ values are significantly 
higher (+0.34 and +0.71 V, respectively). The oxidation of [RuCl(ind)(PPh3){P(pyr)3}] is 
-0.200.000.200.400.600.80
Potential (Volt vs Cp2Fe
°/+)
10 µA
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still reversible at different scan rates with an ipc/ipa ratio of 1.0 at 0.8 V/s. However, the 
oxidation of [RuCl(ind){P(pyr)3}2] only shows some reversibility at high scan rates of 0.8 
V/s and 1.6 V/s, with low ipc/ipa ratios of 0.7 to 0.8, respectively, indicating decomposition of 
the oxidized species. It appears that the successive introduction of P(pyr)3 ligands increases 
the oxidation potential of the respective complexes, which is in line with the higher π-acidic 
electron-demand of that ligand. The presence of two P(pyr)3 ligands in 
[RuCl(ind){P(pyr)3}2] destabilize the oxidized species [RuCl(ind){P(pyr)3}2]+ as can be 
seen from the decreased reversibility of the oxidative cyclic voltammogram waves, 
suggesting some decomposition after oxidation, possibly by attack of adventitious 
nucleophiles.  
Overall, the combined X-Ray, NMR and CV data demonstrate that the P(pyr)3 ligand 
shows π-acidic behaviour and it is a weaker σ donor compared to PPh3. However, sterically, 
the P(pyr)3 ligand resembles PPh3, as can be seen from the comparable bond lengths and 
angles for both of them around the ruthenium center. It appears that the tris-N-pyrrolyl 
phosphine has steric properties similar to PPh3, despites its profound impact on the electron 
density at the metal. Consequently, tris-N-pyrrolyl phosphine can be utilized in the synthesis 
of complexes with decreased electron density at the metal but steric properties similar to their 
respective PPh3 derivatives. 
 
Catalytic applications 
We then investigated the new complexes in their ability to catalytically activate 
propargylic alcohols,[29] and we chose the etherification of propargylic alcohols 5 as a test 
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reaction (Table 3).[15a,c] The complexes [RuCl(ind)(PPh3){P(pyr)3}] and 
[RuCl(ind){P(pyr)3}2] themselves did not show catalytic activity for the reaction. However, 
after activation through chloride abstraction using Et3OPF6, we observed catalytic activity. 
After some optimization efforts, we found that 1-2 mol-% of activated 
[RuCl(ind)(PPh3){P(pyr)3}] catalyzed the etherification of a number of propargylic alcohols 
5 to give the corresponding propargyl ethers 6 in 42 to 27% isolated yields (toluene solvent, 
70 to 95 °C for 16-72 h). The complex [RuCl(ind){P(pyr)3}2] showed no catalytic activity for 
the etherification reactions in Table 3, even after activation through chloride abstraction. We 
do currently not have a satisfactory explanation for the different catalytic activities of the two 
complexes in the etherification reactions; it is possible that the alcohol substrates for the 
etherification reaction deactivate the catalytically active species derived from 
[RuCl(ind){P(pyr)3}2]. 
Excess of the alcohol nucleophile over the propargylic alcohol is not required and the 
catalyst load of 1-2 mol-% is lower than that of other catalyst systems.[14]. Some catalytic 
systems reported in the literature perform the etherification reactions in Table 3 using the 
alcohol nucleophile as the solvent.[14] We speculated that the yields could be improved by 
running the reaction in neat alcohols as the solvent and did so for the entries 3 and 4 of Table 
3. In neat n-butanol, only trace quantities of the product were observed and in neat benzylic 
alcohol, conversion to the product was detected by GC, but starting material 5b was still 
present in the reaction mixture. Thus, the reaction is not more efficient utilizing the alcohol 
nucleophiles as the solvent, which we tentatively ascribe to the deactivation of the catalyst by 
the alcohols. 
18 
 
Table 3. Isolated Yields. 
 
We then turned over to carbon centered nucleophiles in the form of diketones (Table 
4), which have previously been utilized for the substitution of the OH unit of propargylic 
alcohols.[14,29d,e] When subjected to the same reaction conditions as in Table 3, we did not 
observe the formation of the corresponding substitution products. Instead, we detected 
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xanthenone derivatives 7 in the crude reaction mixtures when cyclohexane-1,3-dione was 
used as the diketone substrate. Again, after some optimization efforts, we determined that the 
ruthenium complexes [RuCl(ind)(PPh3){P(pyr)3}] and [RuCl(ind){P(pyr)3}2], after 
activation through chloride abstraction, catalyzed the synthesis of the xanthenone derivatives 
7a-c from propargylic alcohols and 2 equivalents of cyclohexane-1,3-dione (80 to 95 °C, 72 
h, 67-22 % isolated yields, Table 4). For propargylic alcohol 5b, we found that the 
corresponding propargylic acetate 5c gave higher yields (Table 4, entry 2). The higher yields 
might be explained through the fact that the acetate group is a better leaving group than OH. 
Furthermore, it has been reported in the literature that carboxylic acids [30] or trifluoro acetic 
acid [16j,k] have a beneficial effect on ruthenium catalyzed isomerization reactions. The 
acetate leaving group might convert to acetic acid after departure, making the catalyst system 
- in line with these literature reports - more efficient.The identity of the xanthenones 7 was 
established through X-Ray analysis of product 7b in Table 4 (Figure 5). For the product 7a, E 
and Z isomers can form during catalysis, and we determined by 1H NMR an Z / E ratio of 
4.1:1 and 8:1 for the transformation of 5b and 5c, respectively. We tentatively assigned the Z 
configuration to the major isomer of this compound by analogy to a closely related 
trisubstituted alkene.[31] Product 7c is known [32] and was isolated as the pure E isomer, as 
determined by NMR and comparison of the chemical shifts with the literature values. The 
high reaction temperatures and somewhat elongated reaction times might promote the 
formation of the thermodynamically more stable E isomer. The xanthenones 7a and b in 
Table 4 are new and xanthene derivatives are known to exhibit pharmaceutical activity.[33]  
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Table 4. Isolated Yields 
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Figure 5. Molecular structure of xanthenone 7b.  
 
When pentane-2,4-dione was used as the diketone (Table 4, entry 5), a related 
reaction took place where the diketone condensed with the rearranged propargylic alcohol to 
give the known conjugated allylidene dione 8, which has previously been synthesized 
utilizing catalytic p-toluenesulfonic acid under reflux conditions.[34]  
In contrast to the etherification reactions in Table 3, it seemed that activated 
[RuCl(ind)(PPh3){P(pyr)3}] and [RuCl(ind){P(pyr)3}2] gave comparable yields in the 
chemistry of Table 4.  
Although the exact mechanism of the reactions remains to be investigated, they can be 
viewed as a tandem isomerization / condensation sequence (Scheme 2).[35,36] Propargylic 
alcohols are known to undergo acid catalyzed Meyer-Schuster rearrangements to their 
corresponding aldehydes 9 (Scheme 2).[14,37] The aldehydes formed from the propargylic 
alcohols in Table 4 can then undergo a double aldol condensation with the enol tautomer of 
the dione followed by a hemi-acetal formation / dehydration sequence as suggested by 
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others.[35,36] Indeed, when 3,3-diphenylacrylaldehyde 9 was utilized in the reaction with 
cyclohexane-1,3-dione, the product 7b was isolated in a somewhat lower yield of 32% (Table 
4, entry 6), suggesting that the aldehyde might be an intermediate for the reaction.  
 
Scheme 2. Tandem isomerization - aldol sequence to give xanthenones 7. 
 
The formation of xanthenones from aldehydes and diketones is, in principle, known, 
and has been reported to be catalyzed by Brønsted [38] or Lewis acids, [35,39] catalyst free [36] 
or by iodine.[40] However, to the best of our knowledge, the chemistry in Table 4 and 
Scheme 2 represents the first example of the ruthenium catalyzed conversion of propargylic 
alcohols (not aldehydes) to xanthenones, and the first ruthenium catalyzed version of the 
reaction. A gold catalyzed conversion of propargylic alcohols to xanthenones has previously 
been described in the literature.[41] Further investigations into the mechanism are currently 
underway. 
 
Conclusion 
The synthesis of the first tris-N-pyrrolyl phosphine indenyl ruthenium complexes 
[RuCl(ind)(PPh3){P(pyr)3}] and [RuCl(ind){P(pyr)3}2] is described. As determined through 
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X-Ray analysis and cyclic voltammetry, the tris-N-pyrrolyl phosphine ligand is more π-acidic 
and less σ donating compared to PPh3. However, the steric properties of both ligands in the 
solid state are comparable, as can be seen from the bond lengths and angles associated with 
the ruthenium centers derived from X-Ray data. The new complexes are - after chloride 
abstraction - catalytically active in the etherification of propargylic alcohols and in a tandem 
isomerisation – condensation sequence to give xanthenones.  
 
Experimental 
General. All reactions were carried out under an inert N2 atmosphere using standard 
Schlenk techniques. All chemicals were used as supplied from Sigma-Aldrich unless 
otherwise noted. The complex [RuCl(ind)(PPh3)2] was synthesized following the 
literature.[18] THF was distilled from Na/benzophenone under N2. Ethyl acetate, hexane, 
toluene, CH2Cl2, and ClCH2CH2Cl were used as received. Pyrrole was vacuum distilled over 
CaCl2 prior to use. All propargylic alcohols, alcohols, and ketones were obtained and used as 
provided from Sigma-Aldrich. 1-Phenyl-2-propyn-1-ol and propargyl acetate 5c were 
synthesized according to literature procedures.[42,43]  
NMR spectra for characterization were collected at room temperature on a Varian Unity 
300 MHz or Bruker Avance 300 MHz instrument; all chemical shifts (δ) are reported in ppm 
and are referenced to a residual solvent signal. IR spectra were collected on a Thermo Nicolet 
360 FT-IR spectrometer. FAB and exact mass data were collected on a JEOL MStation 
[JMS-700] Mass Spectrometer. Melting points were determined on a Thomas Hoover uni-
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melt capillary melting point apparatus and are uncorrected. Elemental analyses were 
performed by Atlantic Microlab Inc., Norcross, GA, USA.  
 
[RuCl(ind)(PPh3){P(pyr)3}]. A Schlenk flask containing [RuCl(ind)(PPh3)2] (0.658 g, 
0.848 mmol), P(pyr)3 (0.214 g, 0.932 mmol), and THF (8 mL) was refluxed gently for 4 
hours under nitrogen. The solvent was removed via vacuum. The complex was isolated as a 
red solid (0.462 g, 0.622 mmol, 73%) by column chromatography (silica gel 2×15 cm, 
CH2Cl2 as eluent), m.p. 120-122 °C (dec., capillary).  
1H NMR (300 MHz, CDCl3) δ 7.51-7.45 (m, 6H, arom.), 7.33-7.13 (m, 13H, arom.), 6.14 
(br s, 6H), 6.03 (br s, 6H), 4.86 (s, 1H, indenyl), 4.75 (s, 1H, indenyl), 4.54 (s, 1H, indenyl). 
13C{1H} NMR (75 MHz, CDCl3) δ 136.9 (d, JCP=42.6 Hz), 133.5 (d, JCP=10 Hz), 129.8 (s), 
129.6 (s), 129.5 (s), 128.2 (d, JCP=9.5 Hz), 124.9 (s), 124.4 (s), 124.2 (d, JCP=6 Hz), 114.8 (s), 
114.7 (s), 111.2 (d, JCP=6.5 Hz), 93.9 (s), 70.5 (d, JCP=7.5 Hz), 68.3 (d, JCP=6.0 Hz). 31P{1H} 
NMR (121 MHz, CDCl3) δ 122.81 (d, JPP=144 Hz), 40.37 (d, JPP=144 Hz). IR (neat, solid): ṽ 
= 3133 (w), 3052 (w), 2962 (w), 2359 (w), 1454 (m), 1437 (m), 1287 (w), 1178 (s), 1056 (s), 
1036 (s), 732 (s), 696 (m), 623 (m) cm-1. HRMS: calcd. for C39H34N3P2102Ru 708.1249; found 
708.1282, corresponds to [Ru(ind){P(pyr)3}2]+. C39H34N3P2RuCl (743.09): calcd. C 63.03, H 
4.61; found C 62.77, H 4.59. 
[RuCl(ind){P(pyr)3}2]. A Schlenk flask containing [RuCl(ind)(PPh3){P(pyr)3}] (0.140 g, 
0.188 mmol), P(pyr)3 (0.086 g, 0.380 mmol), and THF (5 mL) was refluxed gently for 5 
hours under nitrogen. The solvent was removed via vacuum. The complex was isolated as an 
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orange-yellow solid (0.083 g, 0.117 mmol, 62%) by column chromatography (silica gel 2×15 
cm, CH2Cl2 as eluent), m.p. 126-128 °C (dec., capillary).  
1H NMR (300 MHz, CDCl3) δ 7.19-7.16 (m, 4H, arom.), 6.40 (d, JHH=1.8 Hz, 12H), 6.17 
(d, JHH=1.8Hz, 12H), 5.21 (br s, 2H, indenyl), 4.75 (br s, 1H, indenyl). 13C{1H} NMR (75 
MHz, CDCl3) δ 131.1 (s), 124.4 (s), 124.2 (s), 112.9 (s), 112.4 (s), 96.1 (s), 70.8 (s). 31P{1H} 
NMR (121 MHz, CDCl3) δ 122.2 (s). IR (neat, solid): ṽ = 3127 (w), 3106 (w), 1453 (m), 
1176 (s), 1083 (m), 1055 (s), 1033 (s), 736 (s), 712 (s), 703 (m), 614 (m) cm-1. HRMS: calcd. 
for C33H31N6P2
102Ru 675.1138; found 675.1140, corresponds to [Ru(ind)(PPh3){P(pyr)3}]+. 
C33H31N6P2RuCl (710.08): calcd. C 55.82, H 4.40; found C 55.80, H 4.32. 
 
Activation of [RuCl(ind)(PPh3){P(pyr)3}] through chloride abstraction. 
[RuCl(ind)(PPh3){P(pyr)3}] was placed into a Schlenk tube, along with a molar equivalent of 
triethyloxonium hexafluorphosphate (Et3OPF6), and CH2Cl2. The mixture was stirred under 
N2 for 2-4 hours, followed by removal of the solvent via vacuum to isolate the activated 
catalyst as a dark tan solid. 
 
Representative example for the catalysis reactions in Table 3.  
(2-(benzyloxy)but-3-yn-2-yl)benzene. From 2-phenyl-3-butyn-2-ol (5b, Table 3, entry 3). 
To a small screw-cap vial containing 2-phenyl-3-butyn-2-ol (5b, 0.105 g, 0.72 mmol), benzyl 
alcohol (0.154 g, 1.4 mmol) was added, along with toluene (2 mL). The activated catalyst 
was added (0.010 g, 0.007 mmol, 1 mol-%) and the mixture was heated at 100 °C for 72 
hours. The product 6c was isolated by column chromatography (silica gel, 1.5×15 cm, 2:1 
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hexane/CH2Cl2) as a dark yellow oil (0.071 g, 0.30 mmol, 42%). Spectroscopic data for all 
products in Table 3 are given in the Supporting Information and matched literature 
values.[15c] 
 
Catalysis Reactions Table 4.  
(Z)-9-(2-phenylprop-1-en-1-yl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione 
(7a). From propargyl alcohol 5b (Table 4, entry 1). To a small screw-cap vial containing 2-
phenyl-3-butyn-2-ol (5b, 0.138 g, 0.943 mmol), 1,3-cyclohexanedione (0.267 g, 2.381 mmol) 
was added, along with ClCH2CH2Cl (2 mL).  The activated catalyst was added (0.010 g, 
0.012 mmol, 1.3 mol-%) and mixture was heated at 80 °C for 72 hours.  The product was 
isolated by column chromatography (silica gel, 1.5×15cm, 2:5 ethyl acetate/hexane) as an 
off-white solid (0.066 g, 0.197 mmol, 21%) as a 4.2:1 Z / E mixture of isomers as assessed by 
NMR.  C22H22O3 (334.16): calcd. C 79.02, H 6.63; found C 79.27, H 6.64. Major Z isomer: 
1H NMR (300 MHz, CDCl3) δ 7.53-7.09 (m, 5H, Ph), 5.17 (d, JHH=9.9 Hz, 1H), 4.62 (d, 
JHH=9.9 Hz, 1H), 2.45 (m, 11H), 1.97 (m, 4H); 13C{1H} NMR (75 MHz, CDCl3)  δ  196.7 
(s), 164.5 (s), 144.1 (s), 136.3 (s), 128.7 (s), 128.1 (s), 126.7 (s), 126.1 (s), 116.1 (s), 37.2 (s), 
27.4 (s), 26.2 (s), 20.6 (s), 16.3 (s).   
Minor E isomer: 1H NMR (300 MHz, CDCl3, partial)  δ  5.56 (d, JHH=8.7 Hz), 4.24 (d, 
JHH=8.7 Hz); 13C{1H} NMR (75 MHz, CDCl3)  δ  163.9 (s), 142.6 (s), 138.0 (s), 128.3 (s), 
127.9 (s), 127.3 (s), 126.4 (s), 116.5 (s), 42.3 (s), 38.3 (s), 37.1 (s), 27.8 (s), 27.2 (s), 26.3 (s), 
21.9 (s), 20.3 (s). 
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From propargyl acetate 5c (Table 4, entry 2). To a small screw-cap vial containing 2-
phenyl-3-butyn-2-acetate (5c, 0.175 g, 0.934 mmol), 1,3-cyclohexanedione (0.265 g, 2.36 
mmol) was added, along with ClCH2CH2Cl (2 mL). The activated catalyst was added (0.010 
g, 0.012 mmol, 1.3 mol-%) and the mixture was heated at 80 °C for 72 hours. The product 
was isolated by column chromatography (silica gel, 1.5×15cm, 2:5 ethyl acetate/hexane) as 
an off-white solid (0.145 g, 0.435 mmol, 46%) as a 8:1 mixture of Z / E isomers as assessed 
by NMR. Spectroscopic data matched those reported above.  
 
9-(2,2-diphenylvinyl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione (7b). To a 
small screw-cap vial containing 1,1-diphenylprop-2-yn-1-ol (5d, 0.110 g, 0.528 mmol), 1,3-
cyclohexanedione (0.212 g, 1.35 mmol) was added, along with ClCH2CH2Cl (2 mL). The 
activated catalyst was added (0.010 g, 0.014 mmol, 2.2 mol-%) and the mixture was heated at 
85 °C for 72 hours.  The product was isolated by column chromatography (silica gel, 
1.5×15cm, 2:5 ethyl acetate/hexane) as an off-white solid (0.144 g, 0.363 mmol, 69%).  1H 
NMR (300 MHz, CDCl3)  δ  7.32-7.21 (m, 3H, Ph), 7.06-7.04 (m, 2H, Ph), 6.08 (d, JHH=9 
Hz, 1H), 4.32 (d, JHH=9 Hz, 1H), 2.23 (m, 8H), 1.82 (m, 4H). 13C{1H} NMR (75 MHz, 
CDCl3)  δ  196.6 (s), 164.3 (s), 143.4 (s), 142.1 (s), 139.9 (s), 130.4 (s), 130.3 (s), 127.9 (s), 
127.7 (s), 127.4 (s), 127.0 (s), 126.9 (s), 116.1 (s), 36.9 (s), 27.2 (s), 26.7 (s), 20.6(s).  
C27H24O3 (396.48): calcd. C 81.79, H 6.10; found C 81.63, H 6.12. 
 
(E)-9-styryl-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione (7c).[32] To a small 
screw-cap vial containing 1-phenylprop-2-yn-1-ol (5a, 0.133 g, 1.01 mol), 1,3-
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cyclohexanedione (0.292 g, 2.60 mmol) was added, along with cyclohexane (3 mL). The 
activated catalyst was added (0.016 g, 0.018 mmol, 1.8 mol-%) and mixture was heated at 90 
°C for 16 hours. The product 7c was isolated by column chromatography (silica gel, 
1.5×15cm, 2:5 ethyl acetate/hexane) as an off-white solid (0.095 g, 0.296 mmol, 29%). 1H 
NMR (300 MHz, CDCl3) δ 7.43-7.18 (m, 5H, Ph), 6.27 (s, 2H), 4.72 (s, 1H), 2.52 (m, 8H), 
2.12 (m, 4H). 13C{1H} NMR (75 MHz, CDCl3) δ 196.7 (s), 164.8 (s), 137.5 (s), 131.4 (s), 
130.2 (s), 128.5 (s), 127.3 (s), 126.6 (s), 115.7 (s), 37.2 (s), 28.2 (s), 27.4 (s), 20.6 (s). 
 
3-(3,3-diphenylallylidene)pentane-2,4-dione (8). To a small screw-cap vial containing 
1,1-diphenylprop-2-yn-1-ol (5d, 0.111 g, 0.532 mmol), 2,4-pentanedione (0.146 g, 1.45 
mmol) was added, along with ClCH2CH2Cl (2 mL). The catalyst was added (0.010 g, 0.012 
mmol, 2.4 mol-%) and mixture was heated at 85 °C for 16 hours. The product was isolated as 
tan oil by column chromatography (silica gel, 1.5×12cm, 2:5 ethyl acetate/hexane). The tan 
oil was dried via vacuum and dissolved into warm hexanes. Upon cooling, the product 
formed as an orange-white solid (0.054 g, 0.186 mmol, 34%). 1H NMR (300 MHz, CDCl3) δ 
7.53-7.46 (m, 4H, Ph), 7.41-7.32 (m, 4H, Ph), 7.32-7.25 (m, 2H, Ph), 7.19 (d, JHH=11.8 Hz, 
1H), 7.07 (d, JHH=11.8 Hz, 1H), 2.46 (s, 3H, CH3), 2.20 (s, 3H, CH3’). 13C{1H} NMR (75 
MHz, CDCl3) δ 203.6 (s), 197.5 (s), 155.5 (s), 141.9 (s), 140.8 (s), 140.3 (s), 138.2 (s), 130.6 
(s),129.6 (s), 129.0 (s), 128.7 (s), 128.5 (s), 128.5 (s), 122.2 (s), 31.9 (s), 26.3 (s). C20H18O2 
(290.26): calcd. C 82.73, H 6.25; found C 82.28, H 6.24. 
 
Cyclic Voltammetry 
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Voltammograms were recorded in a three-electrode BAS electrochemical cell in a 
Vacuum Atmospheres HE-493 drybox under an atmosphere of argon in 0.1M NBu4PF6 / 
CH2Cl2 at 298 K. A 1.6 mm Pt disk electrode was used as the working electrode, a platinum 
wire was used as the auxiliary electrode, and a silver wire was used a pseudo-reference 
electrode. Potentials were calibrated against the Cp*2Fe0/+ couple, which is known to occur 
at 0.548V vs the Cp2Fe0/+ couple for this solvent medium.[44] The potentials in this paper can 
be changed to SCE reference values by addition of 0.56 V. Voltammograms were collected at 
0.05 – 1.6 V/s with an EG&G PAR 263A potentiostat interfaced to a computer operated with 
EG&G PAR Model 270 software.  
 
X-ray Structure Determination for [RuCl(ind)(PPh3){P(pyr)3}], 
[RuCl(ind){P(pyr)3}2] and 7b: Crystals of appropriate dimension of the metal complexes 
were obtained by slow diffusion of hexanes into a CH2Cl2 solution of the compounds and for 
7b obtained by layering an ethyl acetate solution of the compound with hexanes.  Crystals 
were mounted on MiTeGen cryoloops in random orientations. Preliminary examination and 
data collection were performed using a Bruker X8 Kappa Apex II Charge Coupled Device 
(CCD) Detector system single crystal X-Ray diffractometer equipped with an Oxford 
Cryostream LT device. All data were collected using graphite monochromated Mo Kα 
radiation (λ= 0.71073 Å) from a fine focus sealed tube X-Ray source. Preliminary unit cell 
constants were determined with a set of 36 narrow frame scans. Typical data sets consist of 
combinations of ω and Φ scan frames with typical scan width of 0.5° and counting time of 15 
seconds/frame at a crystal to detector distance of 4.0 cm. The collected frames were 
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integrated using an orientation matrix determined from the narrow frame scans. Apex II and 
SAINT software packages were used for data collection and data integration.[45] Analysis of 
the integrated data did not show any decay. Final cell constants were determined by global 
refinement of reflections harvested from the complete data set. Collected data were corrected 
for systematic errors using SADABS based on the Laue symmetry using equivalent 
reflections.[45] 
  Crystal data and intensity data collection parameters are listed in Table 1. Structure 
solution and refinement were carried out using the SHELXTL- PLUS software package.[46] 
The structures were solved by direct methods and refined successfully in the space groups, 
Pbca, P21/c and P1, respectively for compounds [RuCl(ind)(PPh3){P(pyr)3}], 
[RuCl(ind){P(pyr)3}2], and 7b. Full matrix least-squares refinements were carried out by 
minimizing Σw(Fo2-Fc2)2. The non-hydrogen atoms were refined anisotropically to 
convergence. All hydrogen atoms were treated using appropriate riding model (AFIX m3). 
The final residual values and structure refinement parameters are listed in Table 1.  
 
Supporting information. Crystallographic data for the structural analysis has been 
deposited with the Cambridge Crystallographic Data Centre, CCDC No. 1053440 for 
compound 7b, CCDC No. 1053441 for complex [RuCl(ind){P(pyr)3}2], and CCDC No. 
1053442 for complex [RuCl(ind)(PPh3){P(pyr)3}]. Copies of this information may be 
obtained free of charge via http://www.ccdc.cam.ac.uk. Supporting information 
(experimental details for the known catalysis products in Table 3, NMR spectra (1H, 13C) for 
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the metal complexes [RuCl(ind)(PPh3){P(pyr)3}] and [RuCl(ind){P(pyr)3}2] and all catalysis 
products) can be found as pdf-document in the online version of this article.  
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The ruthenium pyrrolyl phosphine complexes [RuCl(ind)(PPh3){P(pyr)3}] and 
[RuCl(ind){P(pyr)3}2] were synthesized, and exhibited increased oxidation potentials due to 
the π-acidic pyrrolyl phosphine ligands. The complexes are catalytically active in the 
etherification of propargylic alcohols and in the formation of known and new xanthenones 
from propargylic alcohols and diketones.  
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